Cardio-protective effect of statins in patients with HER2 positive breast cancer receiving trastuzumab therapy

ConclusionsIn women with HER2+ breast cancer receiving trastuzumab-based therapy with or without anthracyclines, concomitant statin use was associated with a lower risk of cardiotoxicity.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research